157 related articles for article (PubMed ID: 11204564)
1. Mechanism of the immune response to human factor VIII in murine hemophilia A.
Wu H; Reding M; Qian J; Okita DK; Parker E; Lollar P; Hoyer LW; Conti-Fine BM
Thromb Haemost; 2001 Jan; 85(1):125-33. PubMed ID: 11204564
[TBL] [Abstract][Full Text] [Related]
2. Blockade of CD40/CD40 ligand interactions prevents induction of factor VIII inhibitors in hemophilic mice but does not induce lasting immune tolerance.
Reipert BM; Sasgary M; Ahmad RU; Auer W; Turecek PL; Schwarz HP
Thromb Haemost; 2001 Dec; 86(6):1345-52. PubMed ID: 11776297
[TBL] [Abstract][Full Text] [Related]
3. Single cell analysis of factor VIII-specific T cells in hemophilic mice after treatment with human factor VIII.
Sasgary M; Ahmad RU; Schwarz HP; Turecek PL; Reipert BM
Thromb Haemost; 2002 Feb; 87(2):266-72. PubMed ID: 11858486
[TBL] [Abstract][Full Text] [Related]
4. Cytokine production by CD4+ T cells specific for coagulation factor VIII in healthy subjects and haemophilia A patients.
Hu G; Guo D; Key NS; Conti-Fine BM
Thromb Haemost; 2007 May; 97(5):788-94. PubMed ID: 17479189
[TBL] [Abstract][Full Text] [Related]
5. Long-term persistence of anti-factor VIII antibody-secreting cells in hemophilic mice after treatment with human factor VIII.
Hausl C; Maier E; Schwarz HP; Ahmad RU; Turecek PL; Dorner F; Reipert BM
Thromb Haemost; 2002 May; 87(5):840-5. PubMed ID: 12038787
[TBL] [Abstract][Full Text] [Related]
6. von Willebrand factor and transforming growth factor-beta modulate immune response against coagulation factor VIII in FVIII-deficient mice.
Kallas A; Kuuse S; Maimets T; Pooga M
Thromb Res; 2007; 120(6):911-9. PubMed ID: 17376515
[TBL] [Abstract][Full Text] [Related]
7. CD4+ T cell response to factor VIII in hemophilia A, acquired hemophilia, and healthy subjects.
Reding MT; Wu H; Krampf M; Okita DK; Diethelm-Okita BM; Key NS; Conti-Fine BM
Thromb Haemost; 1999 Aug; 82(2):509-15. PubMed ID: 10605744
[TBL] [Abstract][Full Text] [Related]
8. Naturally occurring CD4+ CD25+ cells in modulating immune response to administered coagulation factor VIII in factor VIII-deficient mice.
Kallas A; Kuuse S; Maimets T; Pooga M
Haemophilia; 2011 Jan; 17(1):143-51. PubMed ID: 20731724
[TBL] [Abstract][Full Text] [Related]
9. Characterization of antibodies induced by human factor VIII in a murine knockout model of hemophilia A.
Reipert BM; Ahmad RU; Turecek PL; Schwarz HP
Thromb Haemost; 2000 Nov; 84(5):826-32. PubMed ID: 11127864
[TBL] [Abstract][Full Text] [Related]
10. Distribution of Th1- and Th2-induced anti-factor VIII IgG subclasses in congenital and acquired hemophilia patients.
Reding MT; Lei S; Lei H; Green D; Gill J; Conti-Fine BM
Thromb Haemost; 2002 Oct; 88(4):568-75. PubMed ID: 12362225
[TBL] [Abstract][Full Text] [Related]
11. Inhibitor antibody development and T cell response to human factor VIII in murine hemophilia A.
Qian J; Borovok M; Bi L; Kazazian HH; Hoyer LW
Thromb Haemost; 1999 Feb; 81(2):240-4. PubMed ID: 10063999
[TBL] [Abstract][Full Text] [Related]
12. Sensitization of CD4+ T cells to coagulation factor VIII: response in congenital and acquired hemophilia patients and in healthy subjects.
Reding MT; Wu H; Krampf M; Okita DK; Diethelm-Okita BM; Christie BA; Key NS; Conti-Fine BM
Thromb Haemost; 2000 Oct; 84(4):643-52. PubMed ID: 11057864
[TBL] [Abstract][Full Text] [Related]
13. Immunoglobulin isotypes and functional anti-FVIII antibodies in response to FVIII treatment in Balb/c and C57BL/6 haemophilia A mice.
Qadura M; Waters B; Burnett E; Chegeni R; Hough C; Othman M; Lillicrap D
Haemophilia; 2011 Mar; 17(2):288-95. PubMed ID: 21091850
[TBL] [Abstract][Full Text] [Related]
14. Identification of a novel immunodominant cytotoxic T lymphocyte epitope derived from human factor VIII in a murine model of hemophilia A.
Wang W; Merchlinsky M; Inman J; Golding B
Thromb Res; 2005; 116(4):335-44. PubMed ID: 16038719
[TBL] [Abstract][Full Text] [Related]
15. Upregulation of interferon-gamma and interleukin-4, Th cell-derived cytokines by So-Shi-Ho-Tang (Sho-Saiko-To) occurs at the level of antigen presenting cells, but not CD4 T cells.
Kang H; Choi TW; Ahn KS; Lee JY; Ham IH; Choi HY; Shim ES; Sohn NW
J Ethnopharmacol; 2009 May; 123(1):6-14. PubMed ID: 19429332
[TBL] [Abstract][Full Text] [Related]
16. Heterogeneity of the immune response to adenovirus-mediated factor VIII gene therapy in different inbred hemophilic mouse strains.
Rawle FE; Shi CX; Brown B; McKinven A; Tinlin S; Graham FL; Hough C; Lillicrap D
J Gene Med; 2004 Dec; 6(12):1358-68. PubMed ID: 15493040
[TBL] [Abstract][Full Text] [Related]
17. Immune response against serial infusion of factor VIII antigen through an implantable venous-access device system in haemophilia A mice.
Madoiwa S; Kobayashi E; Kashiwakura Y; Sakata A; Yasumoto A; Ohmori T; Mimuro J; Sakata Y
Haemophilia; 2012 May; 18(3):e323-30. PubMed ID: 22044430
[TBL] [Abstract][Full Text] [Related]
18. Induction of immune tolerance by neonatal intravenous injection of human factor VIII in murine hemophilia A.
Madoiwa S; Yamauchi T; Hakamata Y; Kobayashi E; Arai M; Sugo T; Mimuro J; Sakata Y
J Thromb Haemost; 2004 May; 2(5):754-62. PubMed ID: 15099282
[TBL] [Abstract][Full Text] [Related]
19. Mice possess a more limited natural antihuman factor VIII antibody repertoire than humans that is produced disproportionately by marginal zone B cells.
Cormier M; Burnett E; Mo A; Notley C; Tijet N; Christie-Holmes N; Hough C; Lillicrap D
J Thromb Haemost; 2024 Jan; 22(1):76-89. PubMed ID: 37678547
[TBL] [Abstract][Full Text] [Related]
20. Characterization of the immune response to factor VIII using hemophilia A* mice.
Hoyer LW; Qian J
Haematologica; 2000 Oct; 85(10 Suppl):100-2. PubMed ID: 11187859
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
